Screening for Carpal Tunnel Syndrome in Patients With Mucopolysaccharidosis. (May 2020)

• Record Type: Journal Article
• Authors: Patel, Prajay; Antoniou, Georgia; Clark, Damian; Ketteridge, David; Williams, Nicole
• Is Part Of: Journal of child neurology. Volume 35:Number 6(2020:Jun.)
• Page Start: 410
• Page End: 417
• Publication Date: 2020-05
• Subjects: mucopolysaccharidoses -- carpal tunnel syndrome -- pediatrics -- decompression surgery -- inborn genetic diseases; Nervous system -- Diseases -- Periodicals; 618.928
• DOI: 10.1177/0883073820904481
• Languages: English
• ISSNs: 0883-0738

Abstract

Mucopolysaccharidoses (MPSs) are a group of rare lysosomal storage diseases with multisystem manifestations, including carpal tunnel syndrome (CTS). This study comprised a systematic review of literature and hospital guidelines addressing the method and frequency of screening for carpal tunnel syndrome in mucopolysaccharidosis patients and a review of carpal tunnel syndrome in patients seen in the multidisciplinary mucopolysaccharidosis clinic of a pediatric hospital, in order to develop screening recommendations. The literature reported the importance of routine carpal tunnel syndrome screening from early childhood in patients with mucopolysaccharidosis I, II, IV, and VI. Screening methods included physical examination, nerve conduction studies, electromyography, and ultrasonography. Ten of 20 mucopolysaccharidosis patients in our series underwent carpal tunnel syndrome surgery. Given the high incidence of carpal tunnel syndrome at a young age in mucopolysaccharidosis, the authors recommend performing physical examination and obtaining patient and caregiver history for carpal tunnel syndrome every 6 months from the time of mucopolysaccharidosis diagnosis, supplemented by annual nerve conduction studies in cases with poor history or equivocal examination.